It is mainly indicated for the management of anemia caused by either EPO deficiency/insufficiency or resistance in different clinical settings such as chronic kidney disease (CKD), congestive heart failure, chemotherapy, and HIV [6]. The gene discussed is EPO; the disease is chronic kidney disease.